BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (āQuanterixā or the āCompanyā) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that Everett Cunningham has stepped down as President and Chief Executive Officer and as a member of the Companyās Board of Directors (the āBoardā), effective immediately, to accept an opportunity in another area of the healthcare sector. The Board has appointed Jim Gute, Quanterixās Chief Commercial Officer, to serve in the addi
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks

